Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Clay

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
International Immunology|July 20, 2005
Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLsTakuya Osada, Michael A Morse, H Kim Lyerly, et al.
Expert Opinion on Biological Therapy|January 5, 2002
Dendritic cell maturation in active immunotherapy strategiesMichael A Morse, Paul J Mosca, Timothy M Clay, et al.
Journal of Biomedicine & Biotechnology|June 21, 2011
Immunologic monitoring of cellular immune responses in cancer vaccine therapyTheresa L Whiteside, James L Gulley, Timothy M Clay, et al.
International Reviews of Immunology|May 15, 2003
Current status of dendritic cell immunotherapy of malignanciesPaul J Mosca, Timothy M Clay, H Kim Lyerly, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pyloriStephen Y Chui, Timothy M Clay, H Kim Lyerly, et al.
Expert Opinion on Biological Therapy|August 21, 2007
CPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapyYanal M Murad, Timothy M Clay, H Kim Lyerly, et al.
Cancer Treatment and Research|October 11, 2005
Immune monitoringPaul J Mosca, Timothy M Clay, Michael A Morse, et al.
International Reviews of Immunology|May 15, 2003
Redirecting T lymphocyte specificity using T cell receptor genesBarbara L F Kaplan, David C Yu, Timothy M Clay, et al.
International Reviews of Immunology|December 16, 2006
Dendritic cell-based immunotherapyTakuya Osada, Timothy M Clay, Christopher Y Woo, et al.
Expert Review of Vaccines|February 3, 2006
Role of natural killer cell function in dendritic cell-based vaccinesChristopher Y Woo, Timothy M Clay, H Kim Lyerly, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
International Immunology|July 20, 2005
Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLsTakuya Osada, Michael A Morse, H Kim Lyerly, et al.
Expert Opinion on Biological Therapy|January 5, 2002
Dendritic cell maturation in active immunotherapy strategiesMichael A Morse, Paul J Mosca, Timothy M Clay, et al.
Journal of Biomedicine & Biotechnology|June 21, 2011
Immunologic monitoring of cellular immune responses in cancer vaccine therapyTheresa L Whiteside, James L Gulley, Timothy M Clay, et al.
International Reviews of Immunology|May 15, 2003
Current status of dendritic cell immunotherapy of malignanciesPaul J Mosca, Timothy M Clay, H Kim Lyerly, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pyloriStephen Y Chui, Timothy M Clay, H Kim Lyerly, et al.
Expert Opinion on Biological Therapy|August 21, 2007
CPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapyYanal M Murad, Timothy M Clay, H Kim Lyerly, et al.
Cancer Treatment and Research|October 11, 2005
Immune monitoringPaul J Mosca, Timothy M Clay, Michael A Morse, et al.
International Reviews of Immunology|May 15, 2003
Redirecting T lymphocyte specificity using T cell receptor genesBarbara L F Kaplan, David C Yu, Timothy M Clay, et al.
International Reviews of Immunology|December 16, 2006
Dendritic cell-based immunotherapyTakuya Osada, Timothy M Clay, Christopher Y Woo, et al.
Expert Review of Vaccines|February 3, 2006
Role of natural killer cell function in dendritic cell-based vaccinesChristopher Y Woo, Timothy M Clay, H Kim Lyerly, et al.
Pageof 8